Imperva Stock Price, News & Analysis (NASDAQ:IMPV)

$40.80 0.45 (1.12 %)
(As of 12/13/2017 04:00 PM ET)
Previous Close$40.35
Today's Range$40.30 - $41.27
52-Week Range$35.80 - $52.40
Volume232,216 shs
Average Volume430,625 shs
Market Capitalization$1.42 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.78

About Imperva (NASDAQ:IMPV)

Imperva logoImperva, Inc. provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company's products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services. Its Imperva SecureSphere provides database, file and Web application security across various physical and virtual systems in data centers, including in private, public and hybrid cloud computing environments. Its Imperva Incapsula product line provides cloud-based Website security, denial of service protection and performance solutions. Its Imperva Camouflage creates realistic, functional data for development, testing, and training by disguising sensitive information, while maintaining the characteristics of the original data.

Receive IMPV News and Ratings via Email

Sign-up to receive the latest news and ratings for IMPV and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry IT Services & Consulting
Sub-IndustrySystems Software
SectorComputer and Technology
SymbolNASDAQ:IMPV
CUSIP45321L10
Phone650-345-9000

Debt

Debt-to-Equity RatioN/A
Current Ratio2.56%
Quick Ratio2.55%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$264.45 million
Price / Sales5.25
Cash FlowN/A
Price / CashN/A
Book Value$7.06 per share
Price / Book5.78

Profitability

Trailing EPS$0.27
Net Income$-70,270,000.00
Net Margins3.04%
Return on Equity-8.52%
Return on Assets-4.99%

Miscellaneous

Employees993
Outstanding Shares34,010,000

Imperva (NASDAQ:IMPV) Frequently Asked Questions

What is Imperva's stock symbol?

Imperva trades on the NASDAQ under the ticker symbol "IMPV."

How were Imperva's earnings last quarter?

Imperva, Inc. (NASDAQ:IMPV) released its quarterly earnings data on Wednesday, November, 8th. The software maker reported $0.33 earnings per share for the quarter, beating analysts' consensus estimates of $0.22 by $0.11. The software maker earned $83.89 million during the quarter, compared to analyst estimates of $83.79 million. Imperva had a net margin of 3.04% and a negative return on equity of 8.52%. Imperva's revenue was up 22.6% compared to the same quarter last year. During the same period in the previous year, the business earned $0.08 EPS. View Imperva's Earnings History.

When will Imperva make its next earnings announcement?

Imperva is scheduled to release their next quarterly earnings announcement on Wednesday, March, 7th 2018. View Earnings Estimates for Imperva.

What guidance has Imperva issued on next quarter's earnings?

Imperva issued an update on its fourth quarter earnings guidance on Wednesday, November, 8th. The company provided EPS guidance of $0.24-0.29 for the period, compared to the Thomson Reuters consensus estimate of $0.25. The company issued revenue guidance of $89.2-92.2 million, compared to the consensus revenue estimate of $92.69 million.

Where is Imperva's stock going? Where will Imperva's stock price be in 2017?

16 analysts have issued 12-month target prices for Imperva's stock. Their forecasts range from $39.00 to $61.00. On average, they anticipate Imperva's share price to reach $51.33 in the next twelve months. View Analyst Ratings for Imperva.

What are Wall Street analysts saying about Imperva stock?

Here are some recent quotes from research analysts about Imperva stock:

  • 1. According to Zacks Investment Research, "Imperva Inc. is engaged in the development of protection software and services for business applications and databases. The Company delivers innovative technology to give full audit accountability and separation of duties to meet regulatory compliance. It offers SecureSphere Data Security Suite to protect sensitive data from hackers and malicious insiders along with providing a fast and cost-effective route to regulatory compliance and establishes a repeatable process for data risk management. The Company's SecureSphere offers database security solutions to secure sensitive data stored in databases, File Security solutions to protect sensitive files on file servers, storage devices, content repositories, and meet regulatory compliance mandates and Web Application Security solutions to protect web applications from cyber attacks. Imperva Inc. is headquartered in Redwood Shores, California. " (10/24/2017)
  • 2. Evercore ISI analysts commented, "We believe that the quarter was in part helped by the deposition of Skyfence which carried annual operating expenses of ~$25M (and revenue of ~$1M). There is likely a tailwind to margins in 2Q from the deposition as well, despite the company’s ongoing plans to reinvest the savings in growth areas. Management guided to ~7% non-GAAP margins for F17 which compares favorably to consensus of ~5.6% going into the quarter. We continue to believe that the company is working to improve its business but has largely overcome the execution challenges that plagued results last year. We are encouraged by the high level of growth (+64.5% y/y in 1Q17) seen in the company’s subscription offerings which may be further helped by the introduction of FlexProtect which makes form factor (on-prem vs cloud) less relevant. This should offset concerns on the company’s on-premise WAF decline." (5/5/2017)

Who are some of Imperva's key competitors?

Who are Imperva's key executives?

Imperva's management team includes the folowing people:

  • Anthony J. Bettencourt, Chairman of the Board, Vice President - Customer Engagement (Age 56)
  • Christopher S. Hylen, President, Chief Executive Officer, Director (Age 56)
  • Aaron Kuan, Interim Chief Financial Officer (Age 46)
  • Tram T. Phi, Senior Vice President, General Counsel, Corporate Secretary (Age 46)
  • Brett Hooper, Senior Vice President - People (Age 53)
  • Sunil D. Nagdev, Senior Vice President and General Manager, Incapsula, Professional and Customer Services (Age 53)
  • Terry Ray, Chief Technology Officer
  • Amichai Shulman, Chief Scientific Officer (Age 47)
  • Michael D. Mooney, Chief Revenue Officer (Age 56)
  • Allan Roger Tessler, Lead Independent Director (Age 80)

Who owns Imperva stock?

Imperva's stock is owned by many different of retail and institutional investors. Top institutional investors include Eagle Asset Management Inc. (3.83%), JPMorgan Chase & Co. (3.24%), Alyeska Investment Group L.P. (2.67%), Emerald Advisers Inc. PA (1.94%), Emerald Mutual Fund Advisers Trust (1.59%) and Caisse DE Depot ET Placement DU Quebec (1.40%). Company insiders that own Imperva stock include Albert A Pimentel, Amichai Shulman, Anthony J Bettencourt, Mark E Kraynak, Michael D Mooney, Shlomo Kramer, Sunil D Nagdev and Terrence J Schmid. View Institutional Ownership Trends for Imperva.

Who sold Imperva stock? Who is selling Imperva stock?

Imperva's stock was sold by a variety of institutional investors in the last quarter, including Alpine Associates Management Inc., JPMorgan Chase & Co., Artemis Investment Management LLP, OxFORD Asset Management LLP, Dai Ichi Life Insurance Company Ltd, Fisher Asset Management LLC, Retirement Systems of Alabama and Dynamic Technology Lab Private Ltd. Company insiders that have sold Imperva company stock in the last year include Amichai Shulman, Anthony J Bettencourt, Mark E Kraynak, Michael D Mooney, Sunil D Nagdev and Terrence J Schmid. View Insider Buying and Selling for Imperva.

Who bought Imperva stock? Who is buying Imperva stock?

Imperva's stock was acquired by a variety of institutional investors in the last quarter, including Alyeska Investment Group L.P., Caisse DE Depot ET Placement DU Quebec, American Century Companies Inc., Ameriprise Financial Inc., Emerald Advisers Inc. PA, OZ Management LP, Emerald Mutual Fund Advisers Trust and First Trust Advisors LP. View Insider Buying and Selling for Imperva.

How do I buy Imperva stock?

Shares of Imperva can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Imperva's stock price today?

One share of Imperva stock can currently be purchased for approximately $40.80.

How big of a company is Imperva?

Imperva has a market capitalization of $1.42 billion and generates $264.45 million in revenue each year. The software maker earns $-70,270,000.00 in net income (profit) each year or $0.27 on an earnings per share basis. Imperva employs 993 workers across the globe.

How can I contact Imperva?

Imperva's mailing address is 3400 BRIDGE PARKWAY, REDWOOD SHORES CA, 94065. The software maker can be reached via phone at 650-345-9000 or via email at [email protected]


MarketBeat Community Rating for Imperva (IMPV)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  551 (Vote Outperform)
Underperform Votes:  273 (Vote Underperform)
Total Votes:  824
MarketBeat's community ratings are surveys of what our community members think about Imperva and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Imperva (NASDAQ:IMPV) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldBuyBuy
Consensus Rating Score: 2.422.462.572.65
Ratings Breakdown: 2 Sell Rating(s)
10 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
11 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
7 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
6 Hold Rating(s)
16 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $48.64$48.69$49.88$51.21
Price Target Upside: 16.23% upside19.93% upside15.33% upside0.82% upside

Imperva (NASDAQ:IMPV) Consensus Price Target History

Price Target History for Imperva (NASDAQ:IMPV)

Imperva (NASDAQ:IMPV) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/12/2017J P Morgan Chase & CoDowngradeNeutral -> Underweight$45.00HighView Rating Details
11/9/2017Morgan StanleyReiterated RatingUnderweight -> Underweight$39.00N/AView Rating Details
11/9/2017OppenheimerReiterated RatingBuy$55.00N/AView Rating Details
11/9/2017Stifel NicolausReiterated RatingHold -> Hold$50.00 -> $47.00N/AView Rating Details
11/8/2017Evercore ISIReiterated RatingBuy$56.00N/AView Rating Details
10/24/2017KeyCorpReiterated RatingHoldN/AView Rating Details
10/18/2017Royal Bank of CanadaReiterated RatingBuy$49.00N/AView Rating Details
10/16/2017Piper Jaffray CompaniesDowngradeOverweight -> Neutral$42.00N/AView Rating Details
10/10/2017Imperial CapitalLower Price TargetOutperform$57.00 -> $50.00N/AView Rating Details
10/10/2017William BlairDowngradeOutperform -> Market PerformN/AView Rating Details
10/9/2017Wells Fargo & CompanyDowngradeOutperform -> Market PerformN/AView Rating Details
7/28/2017Monness Crespi & HardtBoost Price TargetBuy$55.00 -> $57.00HighView Rating Details
7/13/2017StephensReiterated RatingOverweight$53.00 -> $61.00LowView Rating Details
6/7/2017Susquehanna BancsharesInitiated CoveragePositive -> Positive$60.00LowView Rating Details
3/22/2017DA DavidsonReiterated RatingBuy$55.00LowView Rating Details
2/9/2017BTIG ResearchInitiated CoverageNeutralN/AView Rating Details
11/4/2016NomuraReiterated RatingHold$37.50N/AView Rating Details
11/4/2016Needham & Company LLCUpgradeHold -> Buy$64.00 -> $43.00N/AView Rating Details
11/4/2016MacquarieUpgradeNeutral -> OutperformN/AView Rating Details
10/22/2016Buckingham ResearchReiterated RatingNeutral$45.00N/AView Rating Details
10/15/2016Deutsche BankReiterated RatingHoldN/AView Rating Details
9/25/2016JMP SecuritiesReiterated RatingOutperform$50.00 -> $56.00N/AView Rating Details
9/13/2016WunderlichInitiated CoverageHold$50.00N/AView Rating Details
8/30/2016Pacific CrestDowngradeOverweight -> Sector Weight$47.00 -> $30.00N/AView Rating Details
2/4/2016Topeka Capital MarketsLower Price TargetBuy$80.00 -> $65.00N/AView Rating Details
1/21/2016Northland SecuritiesInitiated CoverageOutperform$77.00N/AView Rating Details
1/11/2016GuggenheimUpgradeNeutral -> BuyN/AView Rating Details
(Data available from 12/13/2015 forward)

Earnings

Imperva (NASDAQ:IMPV) Earnings History and Estimates Chart

Earnings by Quarter for Imperva (NASDAQ:IMPV)

Imperva (NASDAQ IMPV) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/7/2018$0.27N/AView Earnings Details
11/8/2017Q3 2017$0.22$0.33$83.79 million$83.89 millionViewN/AView Earnings Details
7/27/2017Q2 2017$0.05($0.10)$74.30 million$74.44 millionViewN/AView Earnings Details
5/4/2017Q1 2017($0.62)($0.29)$68.16 million$72.31 millionViewListenView Earnings Details
2/8/2017Q416$0.03$0.32$70.22 million$78.40 millionViewListenView Earnings Details
11/3/2016Q316($0.16)$0.08$63.10 million$68.40 millionViewListenView Earnings Details
8/4/2016Q216($0.04)($0.23)$66.06 million$57.87 millionViewListenView Earnings Details
5/5/2016Q116($0.28)($0.25)$59.65 million$59.80 millionViewListenView Earnings Details
2/3/2016Q415$0.15$0.20$68.11 million$72.70 millionViewListenView Earnings Details
10/29/2015Q3($0.05)$0.19$56.52 million$63.30 millionViewListenView Earnings Details
8/6/2015Q215($0.21)($0.08)$48.40 million$53.50 millionViewListenView Earnings Details
5/7/2015Q115($0.38)($0.26)$40.50 million$44.80 millionViewListenView Earnings Details
2/5/2015Q414($0.04)($0.04)$49.80 million$51.40 millionViewListenView Earnings Details
10/30/2014Q314($0.63)($0.51)$40.00 million$42.70 millionViewListenView Earnings Details
5/1/2014Q114($0.41)($0.36)$31.73 million$31.50 millionViewListenView Earnings Details
2/6/2014Q413$0.11$0.12$41.63 million$42.70 millionViewListenView Earnings Details
11/5/2013Q313($0.05)($0.01)$34.43 million$35.10 millionViewListenView Earnings Details
8/7/2013Q2 2013($0.05)($0.10)$31.38 million$31.30 millionViewListenView Earnings Details
5/2/2013Q1 2013($0.10)($0.13)$27.49 million$28.60 millionViewListenView Earnings Details
2/7/2013Q4 2012$0.02$0.06$29.91 million$31.80 millionViewListenView Earnings Details
8/9/2012($0.05)($0.02)ViewN/AView Earnings Details
5/3/2012($0.13)($0.12)ViewN/AView Earnings Details
2/9/2012($0.15)($0.05)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Imperva (NASDAQ:IMPV) Earnings Estimates

2017 EPS Consensus Estimate: ($1.83)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171($0.75)($0.75)($0.75)
Q2 20171($0.55)($0.55)($0.55)
Q3 20171($0.38)($0.38)($0.38)
Q4 20171($0.15)($0.15)($0.15)
Q1 20181($0.60)($0.60)($0.60)
Q2 20181($0.51)($0.51)($0.51)
Q3 20181($0.50)($0.50)($0.50)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Imperva (NASDAQ:IMPV)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Imperva (NASDAQ IMPV) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.90%
Institutional Ownership Percentage: 96.95%
Insider Trades by Quarter for Imperva (NASDAQ:IMPV)
Insider Trades by Quarter for Imperva (NASDAQ:IMPV)

Imperva (NASDAQ IMPV) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/24/2017Anthony J BettencourtDirectorSell99,598$43.59$4,341,476.82View SEC Filing  
5/16/2017Sunil D NagdevSVPSell4,857$49.00$237,993.00View SEC Filing  
5/15/2017Amichai ShulmanInsiderSell3,089$48.70$150,434.30View SEC Filing  
5/10/2017Michael D MooneyCROSell52,356$47.51$2,487,433.56View SEC Filing  
4/17/2017Amichai ShulmanInsiderSell3,085$41.97$129,477.45View SEC Filing  
3/15/2017Amichai ShulmanInsiderSell3,085$41.85$129,107.25View SEC Filing  
2/28/2017Mark E KraynakSVPSell45,314$41.63$1,886,421.82View SEC Filing  
2/21/2017Anthony J BettencourtChairmanSell84,863$45.55$3,865,509.65View SEC Filing  
2/21/2017Terrence J SchmidCFOSell4,500$45.53$204,885.00View SEC Filing  
2/16/2017Mark E KraynakSVPSell1,731$46.10$79,799.10View SEC Filing  
2/15/2017Amichai ShulmanInsiderSell3,085$45.91$141,632.35View SEC Filing  
1/17/2017Amichai ShulmanCTOSell3,085$40.60$125,251.00View SEC Filing  
12/21/2016Amichai ShulmanInsiderSell3,085$40.00$123,400.00View SEC Filing  
11/16/2016Mark E KraynakSVPSell3,332$40.16$133,813.12View SEC Filing  
11/15/2016Amichai ShulmanInsiderSell3,085$40.10$123,708.50View SEC Filing  
10/17/2016Amichai ShulmanInsiderSell3,085$48.57$149,838.45View SEC Filing  
10/3/2016Amichai ShulmanInsiderSell938$53.27$49,967.26View SEC Filing  
9/23/2016Amichai ShulmanInsiderSell937$51.00$47,787.00View SEC Filing  
9/23/2016Mark E. KraynakSVPSell5,582$51.00$284,682.00View SEC Filing  
9/15/2016Amichai ShulmanInsiderSell3,085$44.30$136,665.50View SEC Filing  
8/16/2016Mark E KraynakSVPSell2,614$47.73$124,766.22View SEC Filing  
8/15/2016Amichai ShulmanInsiderSell3,085$46.87$144,593.95View SEC Filing  
7/27/2016Amichai ShulmanInsiderSell3,085$46.28$142,773.80View SEC Filing  
7/26/2016Mark E KraynakSVPSell2,967$46.15$136,927.05View SEC Filing  
6/23/2016Shlomo KramerMajor ShareholderSell75,000$45.12$3,384,000.00View SEC Filing  
6/20/2016Shlomo KramerMajor ShareholderSell75,000$40.24$3,018,000.00View SEC Filing  
5/31/2016Terrence J SchmidCFOSell5,000$37.66$188,300.00View SEC Filing  
5/25/2016Anthony J BettencourtCEOSell50,000$36.15$1,807,500.00View SEC Filing  
5/19/2016Shlomo KramerMajor ShareholderSell50,000$34.20$1,710,000.00View SEC Filing  
5/17/2016Shlomo KramerMajor ShareholderSell75,000$33.95$2,546,250.00View SEC Filing  
5/16/2016Terrence J SchmidCFOSell7,000$33.99$237,930.00View SEC Filing  
5/12/2016Shlomo KramerMajor ShareholderSell75,000$34.16$2,562,000.00View SEC Filing  
3/31/2016Mark E. KraynakSVPSell2,758$50.00$137,900.00View SEC Filing  
3/1/2016Amichai ShulmanCTOSell3,000$45.25$135,750.00View SEC Filing  
2/24/2016Terrence J SchmidCFOSell6,500$41.82$271,830.00View SEC Filing  
2/17/2016Mark E KraynakSVPSell2,758$40.04$110,430.32View SEC Filing  
2/8/2016Albert A PimentelDirectorBuy5,000$38.93$194,650.00View SEC Filing  
2/8/2016Amichai ShulmanCTOSell4,150$38.12$158,198.00View SEC Filing  
2/1/2016Amichai ShulmanCTOSell3,000$50.49$151,470.00View SEC Filing  
1/4/2016Amichai ShulmanCTOSell5,812$60.36$350,812.32View SEC Filing  
12/1/2015Amichai ShulmanCTOSell3,000$74.22$222,660.00View SEC Filing  
11/19/2015Mark E. KraynakinsiderSell10,000$75.00$750,000.00View SEC Filing  
11/19/2015Tram T. PhiVPSell1,244$73.26$91,135.44View SEC Filing  
11/16/2015Anthony J. BettencourtCEOSell50,000$69.33$3,466,500.00View SEC Filing  
11/16/2015Mark E. KraynakinsiderSell3,789$68.73$260,417.97View SEC Filing  
11/12/2015Shlomo KramerMajor ShareholderSell100,000$71.65$7,165,000.00View SEC Filing  
11/6/2015Shlomo KramerMajor ShareholderSell50,000$72.14$3,607,000.00View SEC Filing  
11/4/2015Shlomo KramerMajor ShareholderSell25,000$72.05$1,801,250.00View SEC Filing  
11/4/2015Terrence J. SchmidCFOSell938$71.14$66,729.32View SEC Filing  
11/3/2015Shlomo KramerMajor ShareholderSell25,000$72.55$1,813,750.00View SEC Filing  
10/1/2015Amichai ShulmanCTOSell2,813$65.00$182,845.00View SEC Filing  
8/31/2015Terrence J. SchmidCFOSell1,595$61.56$98,188.20View SEC Filing  
8/17/2015Mark E KraynakInsiderSell1,520$71.42$108,558.40View SEC Filing  
7/23/2015Amichai ShulmanCTOSell9,000$70.00$630,000.00View SEC Filing  
5/11/2015Amichai ShulmanCTOSell10,313$51.09$526,891.17View SEC Filing  
5/11/2015Mark E KraynakInsiderSell4,000$55.00$220,000.00View SEC Filing  
4/20/2015Mark E KraynakInsiderSell3,000$47.53$142,590.00View SEC Filing  
1/20/2015Mark E KraynakInsiderSell3,000$44.60$133,800.00View SEC Filing  
1/8/2015Amichai ShulmanCTOSell1,875$50.00$93,750.00View SEC Filing  
12/16/2014Amichai ShulmanCTOSell9,492$50.00$474,600.00View SEC Filing  
12/15/2014Amichai ShulmanCTOSell11,133$50.00$556,650.00View SEC Filing  
12/1/2014Amichai ShulmanCTOSell5,000$42.44$212,200.00View SEC Filing  
11/28/2014Yaniv ShayaVPSell2,512$44.00$110,528.00View SEC Filing  
11/20/2014Mark E KraynakInsiderSell6,140$42.00$257,880.00View SEC Filing  
11/14/2014Yaniv ShayaVPSell20,938$44.52$932,159.76View SEC Filing  
11/13/2014Mark E KraynakInsiderSell2,000$45.00$90,000.00View SEC Filing  
11/11/2014Tram T PhiVPSell10,076$43.50$438,306.00View SEC Filing  
11/4/2014Terrence J SchmidCFOSell20,000$40.73$814,600.00View SEC Filing  
11/3/2014Amichai ShulmanCTOSell5,000$41.09$205,450.00View SEC Filing  
10/31/2014Amichai ShulmanCTOSell7,500$36.56$274,200.00View SEC Filing  
10/31/2014Mark E KraynakInsiderSell2,000$36.56$73,120.00View SEC Filing  
10/6/2014Amichai ShulmanCTOSell2,500$30.00$75,000.00View SEC Filing  
9/2/2014Amichai ShulmanCTOSell5,000$30.00$150,000.00View SEC Filing  
8/21/2014Terrence J SchmidCFOSell15,000$29.07$436,050.00View SEC Filing  
5/23/2014Ralph PisaniVPSell8,613$21.31$183,543.03View SEC Filing  
5/21/2014Terrence SchmidCFOSell15,000$21.26$318,900.00View SEC Filing  
4/7/2014Shlomo KramerCEOSell60,000$50.53$3,031,800.00View SEC Filing  
4/2/2014Shlomo KramerCEOSell40,000$55.67$2,226,800.00View SEC Filing  
1/8/2014Shlomo KramerCEOSell20,000$50.10$1,002,000.00View SEC Filing  
1/7/2014Shlomo KramerCEOSell40,000$49.99$1,999,600.00View SEC Filing  
1/3/2014Shlomo KramerCEOSell40,000$48.31$1,932,400.00View SEC Filing  
1/2/2014Amichai ShulmanCTOSell22,875$47.68$1,090,680.00View SEC Filing  
12/17/2013Amichai ShulmanCTOSell10,090$45.00$454,050.00View SEC Filing  
12/2/2013Amichai ShulmanCTOSell12,410$44.13$547,653.30View SEC Filing  
11/26/2013Yaniv ShayaVPSell5,243$43.92$230,272.56View SEC Filing  
11/21/2013Jason ForgetSVPSell8,558$38.98$333,590.84View SEC Filing  
11/21/2013Terrence SchmidCFOSell11,100$40.26$446,886.00View SEC Filing  
11/21/2013Tram PhiVPSell6,646$39.50$262,517.00View SEC Filing  
11/19/2013Mark KraynakVPSell3,190$37.80$120,582.00View SEC Filing  
8/29/2013Yaniv ShayaVPSell4,375$48.00$210,000.00View SEC Filing  
8/26/2013Jason ForgetSVPSell2,500$47.50$118,750.00View SEC Filing  
8/26/2013Yaniv ShayaVPSell5,000$47.71$238,550.00View SEC Filing  
8/23/2013Terrence SchmidCFOSell2,539$47.20$119,840.80View SEC Filing  
8/21/2013Jason ForgetSVPSell2,500$47.00$117,500.00View SEC Filing  
8/20/2013Terrence SchmidCFOSell10,461$47.03$491,980.83View SEC Filing  
8/16/2013Jason ForgetSVPSell2,062$47.00$96,914.00View SEC Filing  
8/14/2013Tram PhiVPSell5,000$46.00$230,000.00View SEC Filing  
8/13/2013Jason ForgetSVPSell2,000$45.01$90,020.00View SEC Filing  
8/13/2013Mark KraynakVPSell10,000$44.41$444,100.00View SEC Filing  
8/5/2013Amichai ShulmanCTOSell1,086$52.58$57,101.88View SEC Filing  
8/2/2013Amichai ShulmanCTOSell46,140$51.87$2,393,281.80View SEC Filing  
7/3/2013Amichai ShulmanCTOSell3,222$45.21$145,666.62View SEC Filing  
7/1/2013Amichai ShulmanCTOSell16,778$44.94$754,003.32View SEC Filing  
6/3/2013Amichai ShulmanCTOSell20,000$39.49$789,800.00View SEC Filing  
5/30/2013Amichai ShulmanCTOSell10,000$39.93$399,300.00View SEC Filing  
5/30/2013Yaniv ShayaVPSell4,375$40.40$176,750.00View SEC Filing  
5/29/2013Amichai ShulmanCTOSell20,000$39.96$799,200.00View SEC Filing  
5/28/2013Tram T PhiVPSell5,000$40.25$201,250.00View SEC Filing  
5/24/2013Yaniv ShayaVPSell2,250$40.00$90,000.00View SEC Filing  
5/14/2013Yaniv ShayaVPSell10,000$39.00$390,000.00View SEC Filing  
5/13/2013Albert A PimentelDirectorSell10,000$37.93$379,300.00View SEC Filing  
5/13/2013Ralph PisaniVPSell5,000$38.46$192,300.00View SEC Filing  
5/13/2013Terrence J SchmidCFOSell13,000$37.75$490,750.00View SEC Filing  
5/8/2013Jason ForgetSVPSell4,063$37.31$151,590.53View SEC Filing  
3/26/2013Amichai ShulmanCTOSell20,000$38.30$766,000.00View SEC Filing  
2/26/2013Amichai ShulmanCTOSell20,000$36.05$721,000.00View SEC Filing  
12/28/2012Amichai ShulmanCTOSell10,000$31.01$310,100.00View SEC Filing  
12/27/2012Amichai ShulmanCTOSell20,000$30.98$619,600.00View SEC Filing  
12/5/2012Michael BoodaeiDirectorSell30,000$31.48$944,400.00View SEC Filing  
11/27/2012Amichai ShulmanCTOSell20,000$29.06$581,200.00View SEC Filing  
11/7/2012James R TolonenDirectorBuy5,000$31.17$155,850.00View SEC Filing  
11/1/2012Amichai ShulmanCTOSell20,000$31.71$634,200.00View SEC Filing  
10/4/2012Michael BoodaeiDirectorSell30,000$34.03$1,020,900.00View SEC Filing  
9/5/2012Michael BoodaeiDirectorSell20,000$30.35$607,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Imperva (NASDAQ IMPV) News Headlines

Source:
DateHeadline
Critical Survey: Imperva (IMPV) versus Its PeersCritical Survey: Imperva (IMPV) versus Its Peers
www.americanbankingnews.com - December 12 at 9:34 PM
Imperva stock falls after JP Morgan downgrades to underweightImperva stock falls after JP Morgan downgrades to underweight
finance.yahoo.com - December 12 at 3:32 PM
Imperva Named a Leader in DDoS Mitigation Solutions | Business ... - Business Wire (press release)Imperva Named a Leader in DDoS Mitigation Solutions | Business ... - Business Wire (press release)
www.businesswire.com - December 11 at 6:36 PM
Imperva Named a Leader in DDoS Mitigation SolutionsImperva Named a Leader in DDoS Mitigation Solutions
finance.yahoo.com - December 11 at 8:23 AM
Imperva (IMPV) vs. Its Rivals Head to Head ContrastImperva (IMPV) vs. Its Rivals Head to Head Contrast
www.americanbankingnews.com - December 7 at 9:38 PM
Financial Review: Imperva (IMPV) versus Its PeersFinancial Review: Imperva (IMPV) versus Its Peers
www.americanbankingnews.com - December 3 at 5:30 PM
Zacks: Brokerages Expect Imperva, Inc. (IMPV) to Announce $0.27 Earnings Per ShareZacks: Brokerages Expect Imperva, Inc. (IMPV) to Announce $0.27 Earnings Per Share
www.americanbankingnews.com - November 29 at 3:18 PM
Imperva, Inc. (IMPV) Receives Consensus Recommendation of "Hold" from AnalystsImperva, Inc. (IMPV) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - November 19 at 8:02 PM
Traders Purchase Large Volume of Put Options on Imperva (IMPV)Traders Purchase Large Volume of Put Options on Imperva (IMPV)
www.americanbankingnews.com - November 17 at 2:54 AM
Imperva beats Street 1Q forecastsImperva beats Street 1Q forecasts
marketbeat.com - May 4 at 6:34 PM
IMPERVA INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and ExhibitsIMPERVA INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
biz.yahoo.com - May 23 at 4:28 PM
Imperva May Have Been Conservative With Q2 Guidance - BenzingaImperva May Have Been Conservative With Q2 Guidance - Benzinga
www.benzinga.com - May 12 at 9:05 AM
Imperva Inc. (IMPV) Fell To A 3-Month Low Following Q1 Loss - RTT NewsImperva Inc. (IMPV) Fell To A 3-Month Low Following Q1 Loss - RTT News
www.rttnews.com - May 9 at 2:34 PM
IMPERVA INC Files SEC form 10-Q, Quarterly ReportIMPERVA INC Files SEC form 10-Q, Quarterly Report
biz.yahoo.com - May 9 at 6:07 AM
Heres Why Imperva Inc (IMPV) Stock is Down Despite Upbeat Earnings - Bidness ETCHere's Why Imperva Inc (IMPV) Stock is Down Despite Upbeat Earnings - Bidness ETC
www.bidnessetc.com - May 7 at 8:12 AM
Ouch! Why Imperva Inc. Stock PlummetedOuch! Why Imperva Inc. Stock Plummeted
www.fool.com - May 6 at 5:29 PM
Cyber Insecurity Hits FireEye and Imperva as Their Stocks Get CrushedCyber Insecurity Hits FireEye and Imperva as Their Stocks Get Crushed
www.thestreet.com - May 6 at 3:29 PM
Cybersecurity stocks sell off after FireEye, Imperva, and CyberArk reportCybersecurity stocks sell off after FireEye, Imperva, and CyberArk report
seekingalpha.com - May 6 at 2:43 PM
Imperva plunges after issuing soft Q2 sales guidance; Needham downgradesImperva plunges after issuing soft Q2 sales guidance; Needham downgrades
seekingalpha.com - May 6 at 11:27 AM
Imperva Inc Earnings Call scheduled for 5:00 pm ET todayImperva Inc Earnings Call scheduled for 5:00 pm ET today
biz.yahoo.com - May 5 at 5:00 PM
IMPERVA INC Files SEC form 8-K, Results of Operations and Financial Condition, Material Modification to Rights of SecIMPERVA INC Files SEC form 8-K, Results of Operations and Financial Condition, Material Modification to Rights of Sec
biz.yahoo.com - May 5 at 4:13 PM
Q1 2016 Imperva Inc Earnings Release - After Market CloseQ1 2016 Imperva Inc Earnings Release - After Market Close
biz.yahoo.com - May 5 at 7:07 AM

SEC Filings

Imperva (NASDAQ:IMPV) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Imperva (NASDAQ:IMPV) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Imperva (NASDAQ IMPV) Stock Chart for Wednesday, December, 13, 2017

Loading chart…

This page was last updated on 12/13/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.